Clinical trialObsWithdrawn
Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers
Collection of Biospecimen and Clinical Information in Patients With Gastrointestinal Cancers
- Outcome
- Stopped earlyChange in research focus (Other)
- Phase
- Obs
- Status
- Withdrawn
- Study type
- Observational
- Start
- January 2010
- Expected end
- January 2099
- Enrollment
- 0 participants
- Sites
- 1
- Primary outcomes
- None: Biospecimen will be collected for future research.
- Sponsor
- Other
- Results posted
- No
- Last update
- 28 May 2012
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
We have an active research program in gastrointestinal cancers including clinical trials, epidemiologic, and translational studies. We would like to establish a biospecimen bank linked to useful clinical information in order to learn more about diagnostic, predictive and prognostic markers for gastrointestinal cancers. PRIMARY OBJECTIVES: 1\. To collect and store tumor and normal tissue (previously collected paraffin embedded or frozen specimen) and blood in patients with gastrointestinal (GI) cancers. SECONDARY OBJECTIVES: 1. Collect detailed clinical information via a patient questionnaire that includes demographic, socioeconomic, lifestyle, family, past medical, medication and cancer histories 2. Collect details about the tumor specimen extracted from patient charts.